Boston Scientific Corp. (NYSE:BSX) and Medtronic Inc. (NYSE:MDT) may be locked in an eternal blood feud but the rivals’ search for a new chief executive will look similar, according to BSX CEO J. Raymond Elliott.
“We’re putting a big emphasis on international,” Elliott told a group of analysts in Boston. “Very similar to Medtronic.”